BioCentury
ARTICLE | Company News

Emergent Technologies Inc. cancer, drug delivery news

June 23, 2008 7:00 AM UTC

VC firm Emergent Technologies formed MHC Biologics LLC to develop mAbs to treat cancer and infectious diseases. The company will target major histocompatibility complexes (MHC) and human leukocyte antigen (HLA) peptide complexes. Gregory Pogue, VP of business development at Emergent Technologies, will be president and managing director of the newco, which will be located in Austin, Texas. ...